Swayampakula Ramakanth

Stock Analyst at HC Wainwright & Co.

(2.20)
# 2,683
Out of 4,732 analysts
419
Total ratings
38.1%
Success rate
-3.16%
Average return

Stocks Rated by Swayampakula Ramakanth

Innate Pharma
Jan 17, 2025
Reiterates: Buy
Price Target: $12
Current: $1.69
Upside: +580.47%
Absci
Jan 17, 2025
Reiterates: Buy
Price Target: $7
Current: $2.90
Upside: +141.38%
Nuvalent
Jan 17, 2025
Reiterates: Buy
Price Target: $110
Current: $75.84
Upside: +45.04%
Leap Therapeutics
Jan 16, 2025
Reiterates: Buy
Price Target: $5.5
Current: $2.55
Upside: +115.69%
iTeos Therapeutics
Jan 16, 2025
Reiterates: Buy
Price Target: $21
Current: $8.00
Upside: +162.50%
Vericel
Jan 15, 2025
Reiterates: Buy
Price Target: $60
Current: $59.07
Upside: +1.57%
Quantum-Si incorporated
Jan 14, 2025
Reiterates: Buy
Price Target: $5.5
Current: $2.24
Upside: +145.54%
Elevation Oncology
Jan 14, 2025
Reiterates: Buy
Price Target: $6
Current: $0.71
Upside: +743.53%
Ekso Bionics Holdings
Jan 14, 2025
Reiterates: Buy
Price Target: $9
Current: $0.65
Upside: +1,281.43%
X4 Pharmaceuticals
Jan 14, 2025
Reiterates: Buy
Price Target: $1.5
Current: $0.51
Upside: +195.51%
Reiterates: Buy
Price Target: $22
Current: $14.31
Upside: +53.74%
Reiterates: Buy
Price Target: $7
Current: $0.71
Upside: +885.92%
Reiterates: Buy
Price Target: $33
Current: $13.34
Upside: +147.38%
Reiterates: Buy
Price Target: $25
Current: $17.64
Upside: +41.72%
Maintains: Buy
Price Target: $11
Current: $4.89
Upside: +124.95%
Maintains: Buy
Price Target: $15$17
Current: $14.41
Upside: +17.97%
Reiterates: Buy
Price Target: $7$5
Current: $1.50
Upside: +233.33%
Reiterates: Buy
Price Target: $25
Current: $1.74
Upside: +1,336.78%
Maintains: Buy
Price Target: $22$25
Current: $15.90
Upside: +57.23%
Maintains: Buy
Price Target: $9$7
Current: $0.53
Upside: +1,220.51%
Reiterates: Buy
Price Target: $18
Current: $1.33
Upside: +1,215.79%
Reiterates: Buy
Price Target: $10
Current: $1.15
Upside: +769.57%
Maintains: Buy
Price Target: $63$70
Current: $40.72
Upside: +71.91%
Reiterates: Buy
Price Target: $11
Current: $4.03
Upside: +172.95%
Reiterates: Buy
Price Target: $8
Current: $0.30
Upside: +2,600.88%
Reiterates: Buy
Price Target: $5
Current: $2.76
Upside: +81.16%
Reiterates: Buy
Price Target: $27
Current: $10.93
Upside: +147.03%
Reiterates: Buy
Price Target: $4
Current: $1.11
Upside: +260.36%
Downgrades: Neutral
Price Target: n/a
Current: $1.21
Upside: -
Reiterates: Buy
Price Target: $13
Current: $1.64
Upside: +692.68%
Reiterates: Buy
Price Target: $40
Current: $20.00
Upside: +100.00%
Reiterates: Buy
Price Target: $14
Current: $3.09
Upside: +353.07%
Reiterates: Buy
Price Target: $80
Current: $55.31
Upside: +44.64%
Reiterates: Buy
Price Target: $19
Current: $2.17
Upside: +775.58%
Downgrades: Neutral
Price Target: $3$0.95
Current: $0.80
Upside: +18.75%
Reiterates: Buy
Price Target: $3.5
Current: $1.96
Upside: +78.57%
Reiterates: Buy
Price Target: $11
Current: $9.12
Upside: +20.61%
Reiterates: Buy
Price Target: $20
Current: $3.09
Upside: +547.25%
Reiterates: Buy
Price Target: $5
Current: $0.60
Upside: +733.33%
Initiates: Buy
Price Target: $9
Current: $3.27
Upside: +175.23%
Downgrades: Neutral
Price Target: n/a
Current: $1.80
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $5.00
Upside: -
Reiterates: Buy
Price Target: $9
Current: $0.94
Upside: +857.45%
Maintains: Buy
Price Target: $150$25
Current: $2.30
Upside: +986.96%
Initiates: Buy
Price Target: $5
Current: $1.84
Upside: +171.74%
Maintains: Buy
Price Target: $3$4
Current: $0.24
Upside: +1,542.71%
Maintains: Buy
Price Target: $3$12
Current: $2.62
Upside: +358.02%
Maintains: Buy
Price Target: $25$20
Current: $0.49
Upside: +3,956.80%
Downgrades: Neutral
Price Target: n/a
Current: $17.61
Upside: -
Maintains: Buy
Price Target: $150$80
Current: $1.95
Upside: +4,002.56%
Maintains: Buy
Price Target: $9.5$6
Current: $5.01
Upside: +19.76%
Maintains: Buy
Price Target: $20$15
Current: $6.45
Upside: +132.56%
Maintains: Buy
Price Target: $30$33
Current: $5.33
Upside: +519.14%
Reiterates: Buy
Price Target: $8$9.5
Current: $11.57
Upside: -17.89%
Reiterates: Buy
Price Target: $18,000$14,000
Current: $5.64
Upside: +248,272.27%